The SLICC inception cohort for atherosclerosis

Current Rheumatology Reports

Volumn 10, Issue 4, 2008, Pages 281-285

  Urowitz, Murray B ^a   Gladman, Dafna D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ATHEROGENESIS; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PREVALENCE; REVIEW; SEX DIFFERENCE; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; WAIST HIP RATIO; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; REGISTER;

ADULT; AGED; ATHEROSCLEROSIS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREVALENCE; REGISTRIES;

EID: 53249123494     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-008-0045-2     Document Type: Review

References (28)

1. Isenberg DA, Gladman D: The Systemic Lupus International Collaborating Clinics Group - origins and outcomes. Lupus 2001, 10:375-377.
2. Isenberg D, Bacon P, Bombardier C, et al.: Criteria for assessing disease activity in systemic lupus erythematosus. J Rheumatol 1989, 16:1395-1396.
3. Gladman DD, Goldsmith CH, Urowitz MB, et al.: Crosscultural validation of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol 1992, 19:608-611.
4. Gladman DD, Goldsmith CH, Urowitz MB, et al.: Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: International validation. J Rheumatol 1994, 21:1468-1471.
5. Gladman D, Ginzler E, Goldsmith C, et al.: Workshop report - Systemic lupus international collaborative clinics: Development of a damage index in systemic lupus erythematosus. J Rheumatol 1992, 19:1820-1821.
6. Gladman D, Ginzler E, Goldsmith C, et al.: The development and initial validation of the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996, 39:363-369.
7. Gladman D, Urowitz MB, Goldsmith C, et al.: The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:809-813.
8. Gladman DD, Goldsmith C, Urowitz M, et al.: The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000, 17:373-376.
9. Isenberg D, Petri M, Goldsmith C, et al.: Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol 1996, 23:1953-1955.
10. Manzi S, Meilahn EN, Rairie JE, et al.: Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Amer J Epidemiol 1997, 145:408-415.
11. Petri M, Perez-Gutthan S, Spence D, et al.: Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Amer J Med 1992, 93:513-519.
12. Gladman DD, Urowitz MB: Morbidity in systemic lupus erythematosus. J Rheumatol 1987, 14(Suppl 13):223-226.
13. Manzi S, Selzer F, Sutton-Tyrrel K, et al.: Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999, 42:51-60.
14. Gladman DD, Ibañez D, Urowitz MB: Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002, 29:288-291.
15. Urowitz MB, Gladman D, Ibañez D, et al.: Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: Data from an international inception cohort. Lupus 2007, 16:1731-1735.
16. Urowitz MB, Gladman D, Ibañez D, et al.; Systemic Lupus International Collaborating Clinics: Accumulation of coronary artery disease risk factors over 3 years: Data from an international inception cohort. Arthritis Rheum 2008, 59:176-180.
17. Urowitz MB, Gladman DD, Ibañez D, et al.: Accumulation of atherosclerotic risk factors over 3 years by ethnicity in an international inception cohort. Arthritis Rheum 2006, 54(Suppl 9):S455.
18. Rahman P, Urowitz MB, Gladman DD, et al.: Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol 1999, 26:2363-2368.
19. Esdaile JM, Abrahamowicz M, Grodzicky T, et al.: Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001, 44:2331-2337.
20. Urowitz MB, Gladman DD, IbaÑez D, et al.: Disease outcomes in the first 4 years of systemic lupus erythematosus: Results from the SLICC inception cohort. Arthritis Rheum 2007, 56(Suppl 9):S454.
21. Urowitz MB, Gladman DD, Fortin PR, et al.: Systemic Lupus International Collaborating Clinics (SLICC) inception cohort registry to study risk for atherosclerosis: Metabolic syndrome, prevalence and associated factors. Arthritis Rheum 2006, 54(Suppl 9):S282.
22. Urowitz MB, Gladman DD, IbaÑez D, et al.: Atherosclerotic vascular events in a multinational inception cohort of SLE: Description and attribution. Arthritis Rheum 2007, 56(Suppl 9):S821.
23. Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al.: Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study. Arthritis Rheum 2007, 56:265-273.
24. Hanly JG, Urowitz MB, Siannis F, et al.: Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: Results from an international cohort study. Arthritis Rheum 2008, 58:843-853.
25. Bernatsky S, Ramsey-Goldman R, Boivin JF, et al.: An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 2005, 52:1481-1490.
26. Bernatsky S, Boivin JF, Joseph L, et al.: Race/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis Rheum 2005, 53:781-784.
27. Bernatsky S, Ramsey-Gordon R, Rajan R, et al.: Non-Hodgkin's lymphoma in systemic lupus erythematosus. Ann Rheum Dis 2005, 64:1507-1509.
28. Bernatsky S, Boivin JF, Joseph L, et al.: The relationship between cancer and medication exposures in systemic lupus erythematosus: A case-cohort study. Ann Rheum Dis 2008, 67:74-79.